Recent advances in managing lower urinary tract infections

F1000Res. 2018 Dec 21:7:F1000 Faculty Rev-1964. doi: 10.12688/f1000research.16245.1. eCollection 2018.

Abstract

Urinary tract infections (UTIs) are among the most common bacterial infections. Traditionally, all symptomatic UTIs are tested and treated. The use of antibiotics has resulted in an antibiotic resistance crisis, and we have limited options for managing UTIs. Currently, we live in the era of antimicrobial resistance and may live in other eras like the era of the microbiome. New insights might provide an opportunity to prevent the overuse and misuse of antibiotics and could enable the development of innovate managing strategies.

Keywords: Urinary tract infections; antimicrobial resistance; microbiome.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Disease Management
  • Drug Resistance, Bacterial*
  • Humans
  • Microbiota / drug effects
  • Urinary Tract / microbiology
  • Urinary Tract Infections / drug therapy*

Substances

  • Anti-Bacterial Agents

Grants and funding

The author(s) declared that no grants were involved in supporting this work.